Author(s): Lu L, Liu Q, Du L, Jiang S
Abstract Share this page
Abstract Middle East respiratory syndrome coronavirus (MERS-CoV), a novel human coronavirus that caused outbreaks of a SARS-like illness in the Middle East, is now considered a threat to global public health. This review discusses the challenges in identifying the source of this fatal virus and developing effective and safe anti-MERS-CoV vaccines and therapeutics in order to control its spread and to combat any future pandemic. Copyright © 2013 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
This article was published in Microbes Infect
and referenced in Journal of Antivirals & Antiretrovirals